| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8276996 | Journal of the Neurological Sciences | 2014 | 5 Pages |
Abstract
Different types of DMTs may improve some aspects of cognitive function in patients with MS. Treatment with Avonex and Rebif (Interferon beta-1a preparations) were more helpful in resolving the cognitive impairments in MS patients compared to Betaferon (Interferon beta-1b) as investigated in this study.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Naghmeh Mokhber, Amir Azarpazhooh, Elias Orouji, Stephen M. Rao, Bita Khorram, Mohammad Ali Sahraian, Mohsen Foroghipoor, Morteza Modares Gharavi, Sorayya Kakhi, Karim Nikkhah, Mahmoud Reza Azarpazhooh,